New Products
Protagen has released its first two protein biochips, UNIchip AV-400 and UNIchip AV-VAR, designed for antibody validation, or use with antibody-like molecules.
The UNIchip AV-400 contains 400 predefined and purified human proteins on a nitrocellulose-coated glass side, which represent a cross section of all cellular proteins. The UNIchipAV-VAR, in contrast, contains 400 proteins which are focused on different gene ontology classes, which can be chosen by the customer.
Dynal, a subsidiary of Invitrogen, announced this week the release of its Dynabeads RPC 18. The beads offer an alternative to chromatography columns and spin columns. Based on reverse- phase chromatography or weak cation exchange, these beads can fractionate mixed protein and peptide samples quickly and easily for downstream analysis such as mass spectrometry, the company said.
Movers & Shakers
Brent Keller has been appointed general manager of Kreatech Biotechnology USA, Kreatech's new San Diego-based US office, the Amsterdam, Netherlands-based company said this week. He is currently Kreatech's vice president for commercial operations, working for the company part-time. He holds an MBA in strategic planning and marketing from Pepperdine University and a BS in biology, along with graduate training in viral immunology, from Rensselaer Polytechnic Institute.
Michael Schubert has been promoted to executive vice president and Ian Sanders to vice president for European life science sales of Bruker Daltonics, the company said last week.
Schubert retains his previous responsibilities for Bruker Daltonics' global R&D management, and remains managing director of Bruker Daltonik in Bremen and Leipzig, Germany. In addition, he now also assumes responsibility for the company's life-science mass spectrometry business in the Americas. Schubert holds a doctorate in physics from the University of Hamburg, Germany.
Sanders was previously assistant vice president. He also continues in his role as managing director of Bruker Daltonik. Schubert holds a PhD in drug discovery technology from the University of Bath, UK.
Jean-Paul Mangeolle has been promoted to president of the bioprocess division of Millipore, the company said this week. He used to be vice president of worldwide field operations for the same division. Mangeolle holds an MS in chemical engineering from the University of Montpellier in France and a BS BA in environmental engineering from the University of Chambery, France.